Immunovant, Inc. (IMVT)
NASDAQ: IMVT · IEX Real-Time Price · USD
32.31
-0.21 (-0.65%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Immunovant Market Cap
Immunovant has a market cap or net worth of $4.65 billion as of March 28, 2024. Its market cap has increased by 125.32% in one year.
Market Cap
4.65B
Enterprise Value
3.96B
1-Year Change
125.32%
Ranking
Category
Stock Price
$32.31
Market Cap Chart
Since May 10, 2019, Immunovant's market cap has increased from $128.30M to $4.65B, an increase of 3,523.20%. That is a compound annual growth rate of 108.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 4.69B | -0.65% |
Mar 27, 2024 | 4.72B | 3.47% |
Mar 26, 2024 | 4.57B | 0.67% |
Mar 25, 2024 | 4.54B | -3.04% |
Mar 22, 2024 | 4.68B | -2.69% |
Mar 21, 2024 | 4.81B | 4.81% |
Mar 20, 2024 | 4.59B | 1.54% |
Mar 19, 2024 | 4.52B | 2.71% |
Mar 18, 2024 | 4.40B | -0.85% |
Mar 15, 2024 | 4.44B | -0.55% |
Mar 14, 2024 | 4.46B | -3.52% |
Mar 13, 2024 | 4.62B | 1.02% |
Mar 12, 2024 | 4.58B | -1.38% |
Mar 11, 2024 | 4.64B | 0.79% |
Mar 8, 2024 | 4.60B | -2.31% |
Mar 7, 2024 | 4.71B | -1.88% |
Mar 6, 2024 | 4.80B | -2.68% |
Mar 5, 2024 | 4.94B | -2.22% |
Mar 4, 2024 | 5.05B | -1.59% |
Mar 1, 2024 | 5.13B | -0.20% |
Feb 29, 2024 | 5.14B | -6.08% |
Feb 28, 2024 | 5.47B | -1.82% |
Feb 27, 2024 | 5.57B | 0.55% |
Feb 26, 2024 | 5.54B | 3.11% |
Feb 23, 2024 | 5.38B | 2.81% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Halozyme Therapeutics | 5.17B |
Doximity | 5.04B |
Krystal Biotech | 5.01B |
Nuvalent | 4.91B |
Organon & Co. | 4.81B |
Glaukos | 4.63B |
Alkermes | 4.55B |
Biohaven Pharmaceutical Holding Company | 4.54B |